AGP Picks
View all

Golden State Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Golden State Newswire.

Press releases published on November 12, 2026

NeoVolta Reports Financial Results for Quarter Ended September 30, 2026
MediaAlpha Announces $16 Million Private Stock Repurchase
Equillium Reports Third Quarter 2026 Financial Results and Recent Corporate and Clinical Highlights
Snail, Inc. Reports Third Quarter 2026 Financial Results
Arcadia Biosciences (RKDA) Announces Third Quarter 2026 Financial Results and Business Highlights
Wealthfront to Announce Fiscal Third Quarter 2027 Financial Results on December 3, 2026
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results
Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
CapsoVision Reports Third Quarter 2026 Financial Results
Navitas Files Patent Infringement Lawsuit Against Newly Announced Renesas GaN Products
Oportun to Present at Stephens NASH2026 Annual Investor Conference
Cerebras Systems Delivers Record Revenue in Third Quarter 2026, Raises Full-Year Outlook
Codexis Reports Third Quarter 2026 Financial Results and Provides Business Update
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Iovance Biotherapeutics to Present at Upcoming Conference
Cibus Reports Third Quarter Financial Results and Provides Business Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Golden State Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.